Humphrey L J, Moore D L, Lytle G H
Department of Surgery, Oral Roberts School of Medicine, Tulsa, Oklahoma.
J Surg Oncol. 1990 Feb;43(2):88-91. doi: 10.1002/jso.2930430206.
With the popularity of breast-conserving treatment plans, the natural history of "breast recurrence" in the ipsilateral breast must be distinguished from local recurrence following modified radical mastectomy. Hence, this study considers those patients who develop skin or chest wall recurrence after modified radical mastectomy, whether as a primary procedure or for patients with "breast recurrence" after partial mastectomy. The incidence of postmastectomy locally recurrent breast cancer following modified radical mastectomy (MRM) and adjuvant immunotherapy (IT) is compared to historical controls. The risk factors and treatment of local recurrence in this program as well as in a larger group of patients who recurred after modified radical mastectomy are reported.
随着保乳治疗方案的普及，同侧乳房“乳腺复发”的自然病程必须与改良根治性乳房切除术后的局部复发相区分。因此，本研究纳入了那些在改良根治性乳房切除术后出现皮肤或胸壁复发的患者，无论是作为初次手术，还是针对保乳术后出现“乳腺复发”的患者。将改良根治性乳房切除术（MRM）和辅助免疫治疗（IT）后乳房切除术后局部复发性乳腺癌的发生率与历史对照进行比较。报告了该项目中以及一大组改良根治性乳房切除术后复发患者的局部复发危险因素和治疗情况。
